Upcoming Webinars
-
Ripped from the Headlines: Hot Topics in Life Sciences 2026
The life sciences industry is constantly changing, and equally dynamic are the challenges industry participants encounter. Join Medmarc's Risk Managers to discuss these changes from 2026.
Register for Ripped from the Headlines: Hot Topics in Life Sciences 2026 Read More about Ripped from the Headlines: Hot Topics in Life Sciences 2026 -
Claims 2026: Navigating an Increasingly Difficult World for Life Sciences
Join Andy Hall as he gives an update on the claims and legal environment for life science companies.
Register for Claims 2026: Navigating an Increasingly Difficult World for Life Sciences Read More about Claims 2026: Navigating an Increasingly Difficult World for Life Sciences
Past Webinars
-
Transition From COVID-19 Emergency: Demystify the FDA Requirements to Keep Your Device on The Market
Transition From COVID-19 Emergency: Demystify the FDA Requirements to Keep Your Device on The Market This webinar will cover: • What are the main groups of medical devices impacted? • High level: How to go from EUA to traditional submission (EUA guidance doc). • High level: Phased approach to traditional submission – non-EUA (Phased guidance doc). • Legal ramifications: Overview and Prospective.
Read More about Transition From COVID-19 Emergency: Demystify the FDA Requirements to Keep Your Device on The Market -
Don’t Think You’re a Manufacturer? You Might Be an Apparent Manufacturer: A Look at the Apparent Manufacturer Doctrine
This webinar discusses the Apparent Manufacturer Doctrine under which a nonmanufacturing retailer may be held liable as the manufacturer of a defective product. This doctrine has been ascending in...
Read More about Don’t Think You’re a Manufacturer? You Might Be an Apparent Manufacturer: A Look at the Apparent Manufacturer Doctrine -
Life Sciences Claims 2022: Redefining Normalcy
In this year’s annual year-end wrap-up, a panel including Andy Hall and Lauren Hulbert with Medmarc’s claims department, as well as Jennifer Heis, an attorney with Ulmer Berne, will provide a claims...
Read More about Life Sciences Claims 2022: Redefining Normalcy -
EUAs, 510(k)s and De Novos Demystified: Bringing COVID-19 Tests to the US Market
COVID-19 test developers and regulatory bodies rose to the challenge of quickly supplying the public with the tests necessary to determine infection status. However, many of these tests were brought...
Read More about EUAs, 510(k)s and De Novos Demystified: Bringing COVID-19 Tests to the US Market